121 related articles for article (PubMed ID: 2462283)
1. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
[No Abstract] [Full Text] [Related]
2. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
Kiesewetter H; Jung F; Birk A; Spitzer S
Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
[TBL] [Abstract][Full Text] [Related]
3. [Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution].
Kiesewetter H; Jung F; Blume J; Gerhards M
Dtsch Med Wochenschr; 1986 Aug; 111(35):1307-12. PubMed ID: 2427301
[TBL] [Abstract][Full Text] [Related]
4. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
5. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
6. [Hemodilution in peripheral arterial occlusive disease].
Becsi C; Wehofer D; Weidinger P
Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
[No Abstract] [Full Text] [Related]
7. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
8. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
9. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
10. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
11. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
12. [Treadmill ergometer multistage test: a new alternative in diagnosis and therapeutic control of peripheral arterial occlusive disease].
Weidinger P; Bachl N; Liebenberger S
Vasa Suppl; 1988; 26():48-50. PubMed ID: 2462285
[No Abstract] [Full Text] [Related]
13. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
14. [Isovolemic hemodilution in peripheral arterial occlusive diseases].
Ernst E; Matrai A
Dtsch Med Wochenschr; 1986 Oct; 111(43):1661-2. PubMed ID: 3769813
[No Abstract] [Full Text] [Related]
15. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
[No Abstract] [Full Text] [Related]
16. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
[No Abstract] [Full Text] [Related]
18. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski A; Schmidt HH; Sternitzky R
Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
[No Abstract] [Full Text] [Related]
20. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
